Literature DB >> 20809708

Diffuse and uncontrolled vascular smooth muscle cell proliferation in rapidly progressing pediatric moyamoya disease.

Amy J Reid1, Meenakshi B Bhattacharjee, Ellen S Regalado, Allen L Milewicz, Lisa M El-Hakam, Robert C Dauser, Dianna M Milewicz.   

Abstract

Moyamoya disease is a rare stroke syndrome of unknown etiology resulting from stenosis or occlusion of the supraclinoid internal carotid artery (ICA) in association with an abnormal vascular network in the basal ganglia. Although the highest incidence of moyamoya disease is in pediatric patients, pathology reports have been primarily limited to adult samples and describe occlusive fibrocellular lesions in the intimae of affected arteries. We describe the case of a young girl with primary moyamoya disease who presented at 18 months of age with right hemiparesis following an ischemic stroke. Angiography showed stenosis of the distal left ICA, left middle cerebral artery, and right ICA. An emergent left-sided dural inversion was performed. Recurrent strokes and alternating hemiplegia necessitated a right dural inversion 6 months later. Nonetheless, her aggressive disease proved uniquely refractory to surgical revascularization, and she succumbed to recurrent strokes and neurological deterioration at 2.5 years of age. Pathological specimens revealed a striking bilateral occlusion of the anterior carotid circulation resulting from intimal proliferation of smooth muscle cells (SMCs). Most strikingly, the ascending aorta and the superior mesenteric artery demonstrated similar intimal proliferation, along with SMC proliferation in the media. The systemic pathology involving multiple arteries in this extremely young child, the first case of its kind available for autopsy, suggests that globally uncontrolled SMC proliferation, in the absence of environmental risk factors and likely resulting from an underlying genetic alteration, may be a primary etiologic event leading to moyamoya disease.

Entities:  

Mesh:

Year:  2010        PMID: 20809708     DOI: 10.3171/2010.5.PEDS09505

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  8 in total

1.  RNF213 rare variants in an ethnically diverse population with Moyamoya disease.

Authors:  Alana C Cecchi; Dongchuan Guo; Zhao Ren; Kelly Flynn; Regie Lyn P Santos-Cortez; Suzanne M Leal; Gao T Wang; Ellen S Regalado; Gary K Steinberg; Jay Shendure; Michael J Bamshad; James C Grotta; Deborah A Nickerson; Hariyadarshi Pannu; Dianna M Milewicz
Journal:  Stroke       Date:  2014-10-02       Impact factor: 7.914

Review 2.  Novel Multifaceted Roles for RNF213 Protein.

Authors:  Giuliana Pollaci; Gemma Gorla; Antonella Potenza; Tatiana Carrozzini; Isabella Canavero; Anna Bersano; Laura Gatti
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.

Authors:  S Wallace; D-C Guo; E Regalado; L Mellor-Crummey; M Bamshad; D A Nickerson; R Dauser; N Hanchard; R Marom; E Martin; V Berka; I Sharina; V Ganesan; D Saunders; S A Morris; D M Milewicz
Journal:  Clin Genet       Date:  2016-02-18       Impact factor: 4.438

4.  Clinical and immunopathological features of Moyamoya disease.

Authors:  Runhua Lin; Zeyu Xie; Jianfa Zhang; Hongwu Xu; Hang Su; Xuerui Tan; Dongping Tian; Min Su
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 5.  Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease.

Authors:  Brandon M Fox; Kirsten B Dorschel; Michael T Lawton; John E Wanebo
Journal:  Front Neurol       Date:  2021-09-03       Impact factor: 4.003

6.  Association of De Novo RNF213 Variants With Childhood Onset Moyamoya Disease and Diffuse Occlusive Vasculopathy.

Authors:  Amélie Pinard; Maximillian D J Fiander; Alana C Cecchi; Andrea L Rideout; Mohamed Azouz; Stuart M Fraser; P Daniel McNeely; Simon Walling; Sarah C Novara; Anna C E Hurst; Dongchuan Guo; Sandhya Parkash; Michael J Bamshad; Deborah A Nickerson; Anthony M Vandersteen; Dianna M Milewicz
Journal:  Neurology       Date:  2021-02-10       Impact factor: 9.910

7.  Prospective Screening of Extracranial Systemic Arteriopathy in Young Adults with Moyamoya Disease.

Authors:  Tae Keun Jee; Je Young Yeon; Sung Mok Kim; Oh Young Bang; Jong-Soo Kim; Seung-Chyul Hong
Journal:  J Am Heart Assoc       Date:  2020-09-21       Impact factor: 5.501

Review 8.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.